The collaborative research of Ann L. Oberg, Ph.D., is motivated by her clinical collaborators at Mayo Clinic. She is an established collaborative statistician with broad research experience in cell lines, xenografts, and both retrospective and prospective human studies. Dr. Oberg's research has an emphasis on understanding disease mechanisms and markers of disease in ovarian cancer and pancreatic cancer. Much of her work makes use of large-scale genomic data of various types, such as mRNA expression, protein mass spectrometry and DNA methylation.